pharma news today obesity drugs glp-1 october 2025 GLP‑1 real‑world data for obesity: A new standard for metabolic care Anti-Obesity Drugs Market Report 2025
Description
Research shows that nearly 90% of people with type 2 diabetes also struggle with their weight, and these medications solve both problems at once
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has today approved a new indication for Wegovy (semaglutide) to reduce the risk of overweight and obese adults suffering serious heart problems or strokes.
In India, many people will use it without any of that
Average cost-sharing for a one-month supply of GLP-1 medications ranged from $61 to $93 in 2023
For complete coverage of all related areas of Endocrinology, please visit our on-line FREE web-text, WWW.ENDOTEXT.ORG.
